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Summary 
Cultivation of CD4-CD8-  double negative (DN)  mouse thymocytes and splenocytes  with 
recombinant interleukin 2 (IL2) in the absence of other stimulation results in the generation 
of DN-CD3/TCR+CD16+NKl.l+B220 + large granular lymphocytes (LGL). Purified DNc~- 
/JTCR + thymocytes and splenocytes are CD16 +  IL2Roe- IL2RB +  NK1.1 +  B220- CD5 high. These 
cells are unique in that they express both CD16 and T cell receptor (TCR) which are usually 
mutually exclusive. In addition, they express the natural killer (NK) marker, NKI.1. Cultivation 
of these cells with IL2 for several days results in the generation of DNce-BTCR+CD16+NKl.1 + 
B220+CD5- LGL, suggesting that DNo~-~ffrCR + cells in thymus and spleen are the precursors 
of the DN LGL reported previously.  DN3,-/~TCR +  CD16- NKI.1 - B220  ~ CD5  high thymocytes 
and splenocytes  also  give rise  to DN3,-6TCR+CD16+NKl.l+B220+CD5 -  LGL which,  as 
shown previously with DNo~-~TCR + LGL cells, are cytotoxic against NK-sensitive YAC-1 cells. 
Cytotoxic activity is also induced through either CD16 or the 3,-/~TCR. DNc~-BTCR + and 
DN3,-/~TCR + LGL cells are thus  similar in phenotype to TCR-  NK cells. DNoe-flTCR + 
thymocytes express low levels of the "y subunit of the high affinity immunoglobulin E receptor 
(FceRI3')  molecule, an essential component of CD16 expression.  FceRI3, expression is greatly 
enhanced after cultivation with IL2, resulting in a higher surface expression of CD16. In contrast 
to DNol-~TCR + thymocytes, DN3,-/~TCR + thymocytes do not express detectable  CD16 or 
FceRI3, mRNA but expression of both is induced by cultivation with IL2, leading to the expression 
of CD16 on the surface. Whereas CD16 molecules on both DNc~-~TCR + and DN3,-/~TCR + 
LGL are associated with only FceRI3, homodimers, the TCR on these cells are associated with 
an FceRI3, homodimer and/or CD3~'-FceRI3, heterodimers. These results demonstrate that the 
FceRI3,  subunit is a component of the TCR in a fraction of T  lineage cells. 
T  lymphocytes develop from pluripotential hematopoietic 
stem cells which migrate into the thymus and undergo 
extensive proliferation and differentiation.  Phenotypically, in- 
trathymic precursor  cells  are  characterized  by  a  lack  of 
TCR/CD3,  CD4,  and CD8  on their cell  surface.  These 
CD4-CD8-  double negative (DN) 1 precursor cells lacking 
TCR/CD3  differentiate to  CD4 +CD8 +  double positive 
(DP) cells expressing a low level of TCR/CD3 (TCR-/low) 
via a CD3-CD4-CD8 + immature single positive (SP) stage 
and further differentiate to CD4 +  CD8- or CD4-CD8 + SP 
cells expressing a high level of surface TCR/CD3 complex 
(TCR~g  h) (1). The TCR is responsible for the recognition 
of Ag/MHC and TCR expression is critical  for normal T 
1 Abbreviations used in thispaper: DN, double negative; DP, double positive; 
FceRI'),,  the  "y subunit  of high  affinity  IgE receptor;  PBS-FG, PBS 
supplemented with FCS and gentamycin; sIg, surface immunoglobulin; 
SP, single positive. 
cell development. The transition from DP to SP cells gener- 
ating functionally mature Ag/MHC-specific T cells is called 
tbymic selection and is governed by the spedfidty of the TCR. 
Cells expressing a TCR specific for class II MHC develop 
into CD4 § SP cells and those expressing the TCR specific 
for class I MHC develop into CD8 + SP cells (2-4). 
The TCR is a multimolecular complex formed by three 
groups  of  transmembrane  proteins:  (a)  the  clonotype 
Ag/MHC recognition unit, termed the Tioe-~ (or Ti3'-/~) 
heterodimer (5-9); (b) the highly homologous CD33', CD3/~, 
and CD3E subunits (10, 11); and (c) the structurally distinct 
CD3~" and CD3~/subunits which are products of alternative 
RNA splicing (11, 12). CD3~'and CD3~/form disulfide-linked 
homo- or heterodimers, thereby creating different TCR iso- 
forms (CD3~'2, CD3~'-~,  and CD3~72) in mouse and are im- 
portant in targeting partially assembled TCR complexes to 
the cell surface and transducing stimulatory signals after Ag 
recognition (11-13). 
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significant structural homology to CD3~'and CD3~/(14-16). 
CD3~'/~/and FceRI3, are encoded on the same chromosome 
(mouse chromosome 1), suggesting that CD3~'/~/and FceRI3, 
are derived from a common ancestral gene (17, 18). FceRI3, 
is an essential component of the transmembrane type CD16 
expressed on a variety of cells including NK cells (19, 20). 
Functional similarity between FceRI3, and CD3~'/1/has been 
demonstrated by the ability of members of the CD3~'/~/- 
FceRI~ family to dimerize in distinct receptor systems. CD3~" 
is able to complement the formation of a high affinity IgE 
receptor when mRNAs of FcelLIot, FcetLI~ and CD3~" are 
microinjected into Xenopus oocytes in the absence of FceRI3/ 
(21). Human NK cells express CD3~" as well as FcERI3, in 
association with CD16 in the absence of other TCR compo- 
nents (Tic~-~/, CD33,#e) (22, 23). These results dearly dem- 
onstrate that the CD3g'/~/-FceRI7 family functions in the 
Fc receptor complex. Similarly, transfection of FceRI3, into 
MA5.8, a CD3~'-~/-  variant of a mouse T  call hybridoma 
2B4.11, restored the surface expression of the TCR (24).  In 
addition  to  these recombinant DNA  experiments,  recent 
studies have shown that FceRI3' associates  with the TCR 
in some cell types. A long-term mouse CTL line, CTLL, 
expresses TCRs of at least four different isof0rms (25).  In 
addition to conventional CD3~'/~/dimers, heterodimers be- 
tween FceRI3,, CD3~', and CD3~/are found in CTLL. Long- 
term IL2-driven mouse splenic LGL cultures, also known as 
LAK, express a TCR isoform containing a FceRI  3, homodimer 
in lieu of CD3~'/~/as part of the TCR molecular complex 
(26).  The same FceRI3, containing TCR has been reported 
in tumor-beating mice (27).  Analysis using a mAb against 
human FceRI3, detected this subunit in association with the 
TCR on a fraction of peripheral T lymphocytes and thymo- 
cytes (28). 
Whereas most T  lymphocytes undergo thymic selection 
at  the  TCRI~  +  stage,  recent  studies  have 
identified a cell population that expresses neither CD4 nor 
CD8 but expresses  high levels of c~-BTCR with a skewed 
V gene repertoire in thymus, spleen, lymph node, peripheral 
blood, liver, and hone marrow (29-42). Such DNc~-/5~I'CR  + 
lymphocytes contain autoreactive T lymphocytes and are ex- 
panded in autoimmune Ipr/Ipr  and gid/gld mice (29, 43, 44) 
and in the active stage of human SLE (45).  IL2-driven LGL 
express oL-/~ICRs but lack CD4 or CD8 (26, 46). These LGL 
cells are T  cells because they express TCR. Of note, how- 
ever, these cells also express CD16 and NKI.1, both of which 
are considered markers of NK cells, suggesting that these cells 
are developmentally related to both T and NK cells. In addi- 
tion, LGL express a novel type of TCR containing FceRIy 
as mentioned above (26). To examine the origin of IL2-induced 
LGL,  we herein examined the relationship between IL2- 
induced LGL and DNot-/YI~R + thymocytes and/or spleno- 
cytes in adult animals, based on the observation that these 
LGL cells do not express CD4 or CD8. We found that DNot- 
/3TCR +  thymocytes  and  splenocytes  express  CD16  and 
NKI.1. Furthermore, these cells constitutively express IL2P,  q8 
and can respond to IL2 without other stimulation. In addi- 
tion,  DN3,-/tTCR +  thymocytes and  splenocytes also  re- 
spond to IL2 and become morphologically and functionally 
LGL expressing CD16 and NKI.1, which are not present be- 
fore IL2 cultivation. Both DNc~-BTCR + and DN3,-/~TCR § 
LGL use FceRI3, as a component of their TCR. The develop- 
mental relationship  between DNot-/STCR +  LGL,  DNq,- 
/iTCR + LGL, and TCR-  NK cells and the function of the 
FceRI3, subunit in these cells are discussed. 
Materials and Methods 
Antibodies 
PE-conjugated goat anti-mouse Ig(H+L) and PE-conjugated 
goat anti-rat IgG were obtained from Fischer Scientific Research 
(Pittsburgh,  PA). PE-conjugated GK1.5 (anti-CD4; 47) was ob- 
tained from Becton Dickinson & Co. (San Jose, CA). RED613- 
and RED670-conjugated streptavidin were obtained from GIBCO 
BILL (Gaithersburg, MD). FITC-conjugated  M1/69 (anti-heat stable 
antigen [HSA]; 48) and PE-conjugated 56-5 (anti-CD8/~; 49) were 
obtained from Pharmingen (San Diego, CA). Biotin-conjugated 
R.A3-6B2 (anti-B220; 50) and CG16 (anti-CD5) were obtained from 
Caltag (San Francisco, CA). Hybridomas producing GK1.5, PC61 
(anti-IL21Lot; 51), 53-6 (anti-CD8~;  49) and PK136 (anti-NKl.1; 
52) were obtained from the American Type Culture Collection 
(Rockville, MD). Biotin-conjugated TMB-1 (anti-IL2RB; 53) was 
a kind gift from M. Miyasaka (Tokyo Metropolitan Institute  of 
Medical Science, Tokyo, Japan). Hybridomas producing RM2-2 
(anti-CD2; 54), 2.4G2 (anti-Fc3,RII/III; 55), 3A10 (anti-C~5; 56), 
145-2Cll  (2Cll, anti-CD3~; 57), 500A2 (anti-CD3~; 58), H57- 
597 (H57, anti-C/~; 59), and F23.1 (anti-V/38.1, 2, 3; 60) were kind 
gifts from H. Yagita (Juntendo University, Tokyo,  Japan), J. Unke- 
less (Mount Sinai Medical Center, New York), S. Tonegawa (Mas- 
sachusetts Institute of Technology, Cambridge, MA), J. Bluestone 
(University of Chicago, Chicago, IL), J. P. Allison (University of 
California, Berkeley, CA), R. Kubo (Cytel, La JoUa, CA), and D. 
Raulet (University of California, Berkeley, CA), respectively. All 
mAbs were purified from culture supematant by affinity chroma- 
tography using either protein A-conjugated Scpharose Cb4B or 
protein  C-conjugated Sepharose Cb4B  (Pharmacia, Uppsah, 
Sweden). 3A10, 2Cll, H57, and 53-6 were FITC-conjugated with 
FITC "isomer r' according to the manufacturer's recommenda- 
tion (Molecular  Probes, Eugene, OR). 2.4(32, PC61, PK136, 500A2, 
3A10, H57-597, F23.1, and 53-6 were biotinylated using a biotin 
conjugation kit according to the manufacturer's recommendation 
(Amersham International, Amersham, Bucks, UK). A mAb 1~3A1 
(anti-mouse CD3~'; 61) was purified from ascites fluid by protein 
A-conjugated Sepharose Cb4R Rabbit antisera #387 (anti-mouse 
CD3~'/~/; 62) and 3,666 (anti-mouse FceRI'y; 25) were generous 
gifts from R. D. Klausner and J.-P. Kinet (National Institutes of 
Health (NIH), Bethesda, MD), respectively. 
Purification of Subpopulations  from Thymus and Spleen 
Single cell suspension of thymocytes and splenocytes were ob- 
tained from 8-10-wk-old C57BL/6  mice. To obtain DN thymo- 
cytes and DN-surface immunoglobulin (slg)- splenocytes, 1-2  x 
109 ceils were suspended in 10 ml of PBS supplemented with 2% 
FCS and 10 #g/ml gentamycin  (GIBCO BRL) (PBS-FG) containing 
10 #g/ml each unconjugated GK1.5 and 53-6 mAbs and incubated 
on ice for 45 min. Thymocytes were washed with PBS-FG and 
suspended in 10 ml of PBS-FG containing  50 mg goat anti-rat 
1958  Fcett.I3"  containing TCK on CD3+CD16+NKl.1+B220  + LGL IgG-conjugated magnetic beads (BioMag; Advanced Magnetics, 
Cambridge, MA) which corresponds to 50 ml of original suspen- 
sion. Splenocytes  were washed with PBS-FG and resuspended in 
10 ml of PBS-FG containing 50 mg goat anti-rat IgG-conjugated 
BioMag magnetic  beads and 50 mg goat anti-mouse Ig(H + L)-con- 
jugated BioMag magnetic beads. The cell mixtures were incubated 
on ice for 15 rain with frequent gentle shaking. Cells that bound 
magnetic  beads were removed  by magnet (MACS separator; Miltenyi 
Biotec,  Sunnyvale, CA).  Unbound  cells were recovered and 
resuspended in 10 ml of PBS-FG containing the same amount of 
magnetic beads and the magnetic separation repeated. After two 
cycles of magnetic separations, the yield of DN thymocytes and 
DNslg-  splenocytes was usually 1-2  x  107  and  5-6  x  107, 
respectively, and the purity of the cells was usually >95% (see Figs. 
1 and 3). To purify ot-BTCR  +, ~/-gTCR  +, and TCR- population, 
purified cells were further incubated with PE-conjugated goat 
anti-mouse Ig(H + L) and PE-conjugated goat anti-rat IgG on ice 
for 30 min. After washing, cells were resuspended in 1 ml of PBS- 
FG containing 2% normal rat serum and 10 #g/ml each of FITC- 
conjugated H57 and biotinylated 3A10. After 30 rain of incuba- 
tion, ceils were washed with PBS-FG and resuspended in 1 ml of 
PBS-FG containing 2% normal rat serum and 2.5 #g/ml RED670- 
conjugated streptavidin for 20 min. After washing the cells, DNot- 
flTCK  +  , DN')'-~STCK  +, and TCK- populations were sorted on 
a FACS  |  Vantage (Becton Dickinson). The machine was calibrated 
with total thymocytes unstained or stained with either FITC- 
conjugated  M1/69, PE-conjugated  GK1.5, or biotin-conjugated  53-6 
followed by ILED670-conjugated  streptavidin. Purified cells were 
either examined  by multicolor flow cytometric analysis  or cultured 
in RPMI 1640 supplemented with 1% penicillin/streptomycin, 10 
#g/ml gentamycin, 2 mM t-glutamine, 1% sodium pyruvate, 1% 
MEM nonessential amino acids, 10 mM Hepes, 10% FCS (all from 
GIBCO BRL), 50 #M 2-ME (Sigma  Chemical  Co., St. Louis, MO) 
and 10 ng/ml recombinant human IL2 (Takeda Chemical Indus- 
tries, Osaka, Japan; a generous gift from K. A. Smith, Cornel] 
University, Ithaca, NY). CD4 + SP thymocytes were also obtained 
by cell sorting. Thymocytes were stained with FITC-conjugated 
anti-CDScx (53-6) and PE-conjugated anti-CD4 (GK1.5), and the 
CD4 + SP population was sorted by a FACS Vantage. 
Flow Cytometric Analysis 
To perform multicolor staining analysis of the freshly purified 
DN  thymocytes and DNslg-  splenocytes, cells were first in- 
cubated  with  a  1:100 dilution  each of  PE-conjugated  goat 
anti-mouse Ig(H+L) and PE-conjugated goat anti-rat IgG on ice 
for 30 min. Cultured cells were incubated with a 1:100 dilution 
ofPE-conjugated GK1.5 and PE-conjugated  53-5 on ice for 30 min. 
After washing, cells  were resuspended  in 1 ml of  PBS-FG  containing 
2% normal rat serum and 10 #g/ml each of  FITC-conjugated H57 
for the (x-flTCK  + population or FITC-conjugated 3A10 for the 
3,-STCR + population and the following biotinylated mAbs at 10 
#g/ml: 2.4G2, TMfl-1, PC61, PK136, 500A2, RA3-6B2, CG16, 
3A10 (negative control for the cr  + population), and H57 
(negative control for the 3,-#TCK* population). To block Fc re- 
ceptor-mediated  binding oftbe mAbs at this staining step, 20 #g/ml 
unconjugated 2.4G2 was added except  for the 2.4G2 staining. After 
30 min of incubation, cells were washed with PBS-FG and sus- 
pended in 1 ml of PBS-FG containing 2% normal rat serum and 
2.5 #g/ml RED-613- or RED670-conjugated streptavidin for 20 
min. Flow cytometry was performed with a FACScan  |  (Becton 
Dickinson) calibrated as described  above. For each sample, 25,000- 
50,000 events were collected and data analyzed  on a computer with 
a LYSYS II program (Becton Dickinson). An electronic gate for 
live cells was set through the window of the forward and side 
scatter profiles. By examining the pattern of FITC staining versus 
PE  staining, DNcx-flTCR.  + or DN3"-~TCK  + thymocytes and 
DNslg-c~-flTCK + or DNslg-3,-STCK + splenocytes were then 
gated and further examined for the RED613 or RED670 staining 
patterns. In some cases, the staining patterns were shown by two- 
dimensional plots of FITC versus RED613 or ILED670 staining. 
Immunoprecipitation and Western Blot Analysis 
Cells were lysed at 1-2  x  107 ceUs/ml in TBS (150 mM NaC1, 
20 mM Tris/HCl, pH 7.5) containing 1% digitonin,  10 mM io- 
doacetamide, 5/~g/ml leupeptin, 1 mM PMSF, and 0.24 Trypsin 
inhibitory unit (TIU)/ml aprotinin (all from Sigma Chemical Co.) 
by rotating at 4oC for 2 h. Postnuclear supernatant was incubated 
overnight at 4~  with 20 #1 of packed CNBr-activated Sepharose 
CL-4B beads coupled with various antibodies: 3A10, H57, 2.4G2, 
and 1~3A1 (4-5 mg/ml beads). The bead-antibody-antigen com- 
plexes were pelleted by centrifugation, the supernatant removed, 
and the beads washed once with 15 ml of 0.1% digitonin in TBS, 
three times with I ml of 0.1% digitonin in TBS, once with I ml 
of TBS, and I ml of 20 mM Tris/HC1, pH 7.5. Antigen-antibody 
complexes were solubilized in 20/~1 of nonreducing Laemmli's 
sample buffer at 100oc for 3 min and resolved  by two-dimensional 
nonredudng-reducing SDS-PAGE using 12.5 and 14% acrylamide 
in the 1st and 2nd dimensions, respectively.  After two-dimensional 
SDS-PAGE, proteins were transferred to nitrocellulose (Bin-Red 
Laboratories, Richmond, CA) for I h at 100 V in a solution con- 
sisting of 25 mM Tris, 192 raM glycine, and 20% MeOH. After 
a 2-h room temperature incubation in TBS containing 5% FCS 
and 10 mM NAN3, blots were incubated for I h at room temper- 
ature with antibody #387 or 31666 diluted 1:200 in TBS containing 
5%  FCS and  10 mM NAN3. Finally, immunoreactive proteins 
were visualized using an enhanced chemiluminescence detection 
kit obtained from Amersham International. Prestained molecular 
weight markers (Betbesda Research Laboratories, Bethesda, MD) 
were used for the reference: 44 kD, OVA; 29 kD, carbonic anhy- 
drase; 13 kD, lysozyme. 
PCR Analysis 
Total cellular RNA was prepared from 0.4-1  x  106 cells by the 
vanadyl  ribonuclease  complex  method (63). cDNA copies  were pro- 
duced from total cellular  RNA using an oligo dT primer and AMV 
reverse transcriptase (Molecular Genetics Resources, Tampa, FL) 
and used as templates  for PCK with specific  primers as listed below 
on a Teclme  thermocyeler  using the Gene Amp Kit reagents (Perkin 
Elmer Cetus, Norwalk,  CT) for 40 cycles. 
FcyRII/III.  The sense amplimer 5~ 
GGAACY located at bp 470-489 of FeyRIII and the antisense 
amplimer 5'GGAGC~ACATCACTAGGGAGY  at bp 733-714 in 
the transmembrane region of Fe'/RIII (numbers are according to 
reference 64) were used to detect FcyRIII (CD16). The PCK 
product of Fe3,KIII is a 264-bp fragment. To identify FcyKIIbl 
(lymphocyte  form) and Fc3,RIIb2 (monocyte form), the same sense 
amplimer was used with the antisense  amplimer 5'GCAGCTTCT- 
TCCAGATCAGGY which lies at bp 1232-1213 of FclL'),ILIIbl,  3' 
to the  138-bp insertion found in FcK~/Ilbl as compared with 
FcK'yIIb2. Amplification of FcR3dlbl and FcR~/Ilbz  cDNAs pro- 
duce DNA fragments of 484 and 346 bp, respectively. For PCK, 
the denaturing, annealing, and extension were performed at 94~ 
for 1 rain, 60~  for 1 min and 720C for 0.5 rain, respectively. 
1959  Koyasu The products were run on a 1.5% agarose gel, alkaline blotted to 
Zeta-Probe membrane (Bio-Rad Laboratories) and hybridized to 
the  oligonudeotide  5'GCCTGTCACCAT  ACTGTCC3'  at  bp 
642-661  of Fc3,1LIII and bp 921-940  of Fc3"ILlIbt and F'c3,1LIIbz. 
The oligonucleotide was labeled by 5' phosphoryhtion using poly- 
nncleotide kinase and "y-[s=P]ATP. Hybridization was performed 
in 6x  SSC, 5 ￿  Denhardt's solution, 10 t~g/rul denatured salmon 
sperm DNA, and 0.1% SDS at 52~  The blot was then washed 
for 20 rain in 6x  SSC-0.1% SDS at 52~  and exposed at  -70~ 
to Kodak X-Omat AR x-ray film. 
FceRI~/.  The sense amplimer 5'TGATCGCCAGCTCCCAG- 
CGCY  located at bp  1-20  and the antisense amplimer 5'GTG- 
AGAGTCGAGGATCAGGGY  at bp 530-511 in the FceR.I3, eDNA 
sequence (15) were used. The PCR. product of FceRI~/is a 530-bp 
fragment. The denaturing, annealing, and extension were performed 
at 94~  for I rain, 60~  for I min, and 72~  for 0.5 rain, respec- 
tively. An oligonucleotide 5'GACC'IGGATCTTGAGTCGACY at 
bp 192-173 was used for hybridization as above. 
CD3~.  The  sense  amplimer  5~GAAGCCTACACTGAGA- 
TCGY located at bp 462-481  and the antisense amplimer 5'GGA- 
TGACGTTCTGTGTTCAGY at bp 774-755 in the CD3~" eDNA 
sequence  (14) were used. The PCK product of CD3~" is a 313-bp 
fragment. The denaturing, annealing, and extension were performed 
at 94~  for 1 min, 60~  for 1 min, and 72"C for 0.5 rain, respec- 
tively. An oligonucl~tide 5'GTCTCAGCACTGCCACCY at bp 
533-549  was used for hybridization as above. 
CD3&  The sense  amplimer 5'GGAACACAGCGC~ATTC- 
TGGY located in the first exon (65) and the antisense amplimer 
5'CACCAGCCATGGTGCCCGAG3' in the third exon (bp 289- 
270 in the CD3~ eDNA sequence; 66) were used. The PCP, product 
of CD3# is a 319-bp fragment. The denaturing,  annealing,  and 
extension were performed at 94~  for 1 min, 55~  for 1 min, 
and 720C for 0.5  min, respectively. 
C2/totoxic Assay 
Target cells were hbeled with SlCr (100 #Ci/10' cells) for 1 h 
at  37~  Targets were  then  washed  three  times  and  added  to 
V-bottom microtiter plates at 5,000 cells/well in P,  PMI 1640 con- 
taining 10% FCS and 10 ng/ml IL2. Effector cells were added at 
the indicated ratios in a final volume of 180 ~1. Plates were cen- 
trifuged at 800 rpm for 5 min and then incubated for 4 h at 37~ 
After recentrifugation at 2,000 rpm for 2 rain, 90 #1 were removed 
from each well for assay of gamma radioactivity. Percent specific 
lysis was calculated according to the formula 100  x  [(E -  C)/(M 
-  C)] where E is the experimental value in cpm, C is the control 
value, and M is the maximum release value.  C was determined as 
the average release in control weUs from which effr  cells were 
omitted. M was determined as the avenge release in wells to which 
1% NP-40 was added in place of effeetor ceRs. All determinations 
were performed in triplicate. 
Miscellaneous 
C57BL/6 mice were obtained from The Jackson Laboratory (Bar 
Harbor, ME) and bred in the animal facility at the Dana-Farber 
Cancer Institute.  Con A bhsts were prepared by stimulation of 
lymph node cells with 5/zg/ml Con A for 24 h followed by culti- 
vation of the stimuhted cells in the presence of 10 ng/ml IL2 for 
4 d. Light microscopy was performed under a Leitz Labovert mi- 
croscope equipped with a Hoffmann modulation contrast system. 
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Figure  1.  Flow cytometric analysis of D N thymocytes. (A) DN thymocytes were prepared from C57BL/6 thymocytes by a magnetic purification 
method.  Cells before (a) and after (b) purification were ~amined for their expression of CD4/CD8 by incubation of the cells with mAbs against 
CD4 (GK1.5) and CD8(x (53-6) followed by incubation with PE-conjugated goat anti-rat IgG. Purified DN thymocytes were then stained with FITC- 
conjugated H57 for (x-BTCR  + population (B) or FITC-conjugated 3A10 for 3,-6TCR + popohtion (C) and the following biotinyhted mAbs: (a) 2.4G2 
(anti-Fc~RII/III), (b) TMB-1 (anti-IL21L~), (c) PC61 (anti-IL2Ro  0, (d) PK136 (anti-NKL1), (e) 50(02 (anti-CD3e), ~  ILA3-6B2 (anti-B220), and 
(g) CG16 (anti-CDS). 3A10 (anti-Cfi) and H57 (anti-CB) were used as negative controls for the o~-tYICR  + and the 7-#TCR* popuhtions,  respec- 
tively. To block Fc receptor-mediated binding of the mAbs, unconjugated 2.4G2 was added except for the 2.4<32 staining. At the end, cells were 
incubated with ILED670-conjugated streptavidin as described in Materials and Methods. Flow cytometry was performed with a FACScan  |  (Becton 
Dickinson) and data analyzed on a computer with a LYSYS II program. An dectronic gate for live cells was set through the window of the forward 
and side scatter profiles. By examining the pattern of FITC staining versus PE staining, DNo~-BTCR  + or DN3,-#TCR + thymocytes were then gated 
(squares,  the right) and further examined for the RED670 staining patterns (left). Histograms are presented as overlays  with negative control stainings. 
1960  FceRIv containing TCR on CD3+CD16+NK1.l+B220+  LGL Results 
Purification and Surface Phenotypes of CD4- CD8- TCR ~',  ' 
Thymocytes and Splenocytes.  To examine the developmental 
and  functional  relationships  between  DN-CD3*CD16 + 
LGL and DN-TCK  h~h thymocytes or peripheral DN T cells, 
we first purified and characterized DN-TCRhig  h thymocytes. 
Using repeated depletion of CD4+SP,  CD8+SP,  and DP 
cells from thymocytes by magnetic separation with rat mAbs 
against CD4/CD8 and magnetic beads conjugated with goat 
anti-rat IgG, more than 97% of CD4 and/or CD8 expressing 
cells  were removed (Fig.  1 A).  The surface phenotype of 
purified DN thymocytes was examined by multicolor flow 
cytometry. As shown in Fig.  1 B, the DNa-/3TCK + cells 
express Fc3,KII/III defined by mAb 2.4G2  (a) and NKI.1 
defined by mAb PK136  (d),  neither of which is expressed 
on conventional T lymphocytes (data not shown). These cells 
also express a high level of CD5 defined by mAb CG16 (g) 
and CD2 defined by mAb RM2-2 (data not shown), indi- 
cating that these cells share phenotypes characteristic of ma- 
ture T lymphocytes. Whereas these calls express a high level 
of IL2RB defined by mAb TM/3-1  (Fig.  1 B,  panel b) no 
IL2Kot was detected by mAb PC61 (Fig. 1 B, panel c). Staining 
of these ceils with mAb F23.1 reacting with the V/38 family 
showed that nearly 50% of the calls express members of the 
V/38 family as reported (data not shown; 30).  In contrast, 
the DN3,-STCR + thymocytes (Fig.  1 C) express high levels 
of CD5 and CD2 (data not shown) but Fc3,RII/III, NKI.1, 
and IL2R~ are not detected on these cells. Both populations 
are B220-  as examined by mAb RA3-6B2. 
To purify DN-TCRhis  h splenocytes, magnetic beads con- 
jugated with goat anti-mouse Ig(H+L) were used to remove 
B lymphocytes in addition to rat mAbs against CD4/CD8 
and magnetic beads conjugated with goat anti-rat IgG to 
remove CD4 + and CD8 + cells.  Staining of purified DN 
cells with H57 (anti-Cfl; anti-o~-~CR)  and 500A2 (anti- 
CD3e) reveals that these cells contain at least three popula- 
tions:  DNc~-flTCR +, DN3,-STCR +,  and TCR-  popula- 
tions  (Fig.  2 A).  The TCR-  cells  in  thymus and spleen 
likely represent immature thymocytes and NK cells, respec- 
tively. DNc~-~ICR. + splenocytes have a nearly identical sur- 
face phenotype to that of DNo~-/3TCR + thymocytes except 
that 30-40%  of the DNc~-BTCR + splenocytes do not ex- 
press  NKI.1  (Fig.  2 and data not shown). 
Induction of LGL from DN Thymocytes and Splenocytes by 
11.-2.  Because the/3  subunit of the IL2R  is  thought  to 
transmit proliferative signals,  the DNot-/3TCK §  cells may 
be the precursors of the IL-2-induced LGL observed previ- 
ously (26, 46). To examine this, purified DN thymocytes and 
splenocytes were cultured in the presence ofrIL-2. After sev- 
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Figure 2.  Induction  of LGL by IL2 from purified  DN thymocytes  and DNslg- splenocytes.  (A) DNslg- thymocytes  and splenocytes  were purified 
by magnetic  separation and then stained  with FITC-conjugated  H57 and the following  biotinylated  mAbs: 2.4G2 (anti-Fc3,KII/III),  TMB-1 (anri-IL- 
2RB), PC61 (anti-IL21Lo  0, PK136 (anti-NKl.1), and 500A2 (anti-CD3~). An irrelevant  mAb was used as a negative  control. The final staining was 
with KED613-conjugated  streptavidin. Two-color  profiles for FITC and KED613 of fresh DNslg- ceUs  are shown. (B) Purified  DNslg- splenocytes 
(a) and thymocytes  (b) were cultured in the presence  of IL2 for the indicated  time periods. Ceils were first stained with PE-conjugated  mAbs against 
CD4 (GK1.5), CD8/5 (53-5), and PE-conjugated  goat anti-mouse Ig(H+L) and then stained with FITC-conjugated  H57 and various biotinylated 
mAbs as indicated  (A). The DNcx-~'CR  + fraction  was gated and staining patterns of RED613 on indicated  days during IL2 cultivation are shown. 
1961  Koyasu eral days of cultivation with IL2, cells morphologically char- 
acteristic of LGL were found to be proliferating. Multicolor 
flow  cytometric  analysis  revealed  that  the  DNo~- 
/3TCR+Fc3,tLII/III+NKI.I+  ceils from both thymus and 
spleen were induced to express IL2Rc~ by day 5 and were 
indistinguishable from the long-term IL2-driven LGL reported 
previously (Fig.  2 B; and 26). 
It is possible that these LGL cells result from proliferation 
of a fraction of TCK-  immature cells that express IL2R, 
respond to IL2, and then express o~-BrCR. To rule out this 
possibility and to directly examine whether DN~-BTCR + 
thymocytes are the precursors  of DNc~-~TCR + LGLs, we 
further purified these populations by cell sorting. As shown 
in Fig. 3 A, DN thymocytes purified by magnetic separation 
were further stained  with FITC-conjugated H57 (anti-c~- 
~/CR) and biotin-conjugated 3A10 (anti-3r-~CR) followed 
by RED670-conjugated streptavidin and DN~-~r~CR + and 
DN3,-#TCR + thymocytes were separately sorted. Rcanalysis 
after sorting showed that both populations were >95% pure 
(Fig. 3 A). When these purified cells were cultured in the 
presence of 1[.2, most of the cells survived and started to 
proliferate within a few days. After 2 wk of cultivation, cells 
determined by morphology to be LGL were induced from 
DNc~-~TCR + thymocytes (Fig. 4). To our surprise, DN'~- 
~TCR + cells also responded to IL2 and gave rise to LGL 
of similar morphology (Fig. 4). These results suggest that 
both DNc~-~R  + and DN3,-aTCR* thymocytes respond 
to IL2 and differentiate to LGL.  Furthermore, both cells 
developed a similar phenotype, namdy Fc~ILII/III  +  NKI.1 + 
(Fig.  3, B  and C).  As shown below, the F-~R on these 
cells is CD16.  In contrast to  the cells before cultivation, 
these cells express a high level of B220 and lose the expres- 
sion of CD5. These results indicate that DNc~-BTCR + and 
DN~/-~TCR + thymocytes can proliferate in response to IL2 
in the absence of TCR stimulation and become LGLs. We 
therefore  designate  these cells  as  thymic o~-BICR +  and 
3,-~TCR + LGL. 
Since the surface phenotypes of DNo~-~CR + and DN'y- 
/~TCR + splenocytes were nearly identical to those of DNo~- 
~ffl'CR + and DN"f-6TCR + thymocytes, respectively, except 
that DN~/-#TCR + splenocytes express low levels of IL21L8 
(Fig. 2 and data not shown), we next examined the response 
of DNo~-BTCR +  and DNT-~TCR +  splenocytes  to  IL2. 
o~-BTCR +, 3,-~TCR +, and TCR-  cells were further puri- 
fied from CD4- CD8- slg- cells by cell sorting as described 
above and cultured with IL2. Again, cells of LGL morphology 
were induced within a week of cultivation. Flow cytometric 
analysis showed that these cells were indistinguishable from 
those obtained from thymocytes (Fig.  5). Both c~-BTCR + 
(Fig. 5 A) and 3,-~TCR + LGL (Fig. 5 B) were Fc3,RII/III + 
NKI.1 +  B220 +  CDS-.  These phenotypes were identical to 
those of NK cells (Fig. 5 C) except for the expression of the 
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Figure 3.  Induction of LGL from purified DNot-j~'CR + and DN3~-STCR + thymocytes by IL2. (A) Purification of DNot-~ffrCR + and DN'y-6TCR + 
thymocytes.  Thymocytes (8  x  108) obtained from nine C57BL/6 mice were incubated with mAbs against CD4 (GK1.5) and CDS~ (53-6) and 107 
DN thymocytes were recovered by magnetic separation.  The purity was 97%  as evident by the comparison of the staining patterns between before 
(a) and after (b) separation with mAbs against CD4 (GK1.5) and CD8~ (53-6) followed by PE-conjugated goat anti-rat IgG. Purified DN thymocytes 
were further stained with FITC-conjugated H57 (anti-Cl3) and biotinylated 3A10 (anti-C~) followed by KED670-conjugated streptavidin (c). DNcx-/3- 
TCR + and DN3~-tSTCR  + thymocytes were then sorted by a FACS  |  Vantage and 8.5  x  10  s and 2.9  x  10  s cells were recovered for DN(x-~qCR + 
and DN'y-STCK + tbymocytes, respectively. The purity of DNcx-/3TCR + (d) and DN3~-~TCK + (e) thymocytes was 96 and 97%,  respectively. (B 
and C) Purified DNa-BTCR + and DN'y-~TCR + thymocytes were cultured in the presence of IL2 for 9 d. Resulting c~-~'~R*  (B) and y-6TCK + 
(C) LGL ceUs were then stained with various biotinylated antibodies as indicated, followed by RED670-conjugated streptavidin as described in Fig. 
2. (a) 2.4G2 (anti-Fc3,RII/III), (b) TMtS-1 (anti-IL21LS), (c) PC61 (anti-IL2Kc  0, (d) PK136 (anti-NKl.1), (e) 500A2 (anti-CD3e), (f) RA3-6B2 (anti- 
B220), and (g) CG16 (anti-CDS), 3A10 (anti-C/5; negative control for-the ot-B'l~R + LGL), H57 (anti-CB; negative control for the 3,-/~TCR  + LGL). 
1962  FcdLl~/containing TCR on CD3+CD16+NKl.1+B220 § LGL Figure  4.  Morphology of LGL 
cells.DNa-/YrCR +  thymocytes, 
DN•-6TCR+  thymocytes,  o~-fl 
TCR +,  and 3,-/~TCR + ILL cells 
obtained from the purified DNa- 
BTCR +  and  DN'y-gTCR + 
tbymocytes with IL2 were exam/ned 
under a Ldtz Laboverr microscope 
equipped with a Hoffmann modu- 
htion contrast system and  a 20x ob- 
jective lens.  Bar, 20/~m. 
TCR. We designate these cells  as  splenic ol-flTCR +  and 
3,-STCR + LGL. From the above results, we condude that 
IL2 stimulation of DNot-flTCR + and DNq,-STCR + cells 
from both thymus and spleen generates LGL cells. Whereas 
DNc~-~ICR +  splenocytes have 30-40%  of cells that  do 
not  express NKI.1,  DNc~-flTCR + LGL are nearly 100% 
NKI.1 +.  It  is  unknown  whether  only NKI.1 +  cells  ex- 
pand or NKI.1-  cells acquire NKI.1 expression in response 
to IL2. 
Cytotoxic Activity  of ~/~TCR + LGL.  NK  cells  show 
strong cytotoxic activity against certain tumor  cells such  as 
YAC-1 cells and, in addition, disphy antibody-dependent cel- 
lular cytotoxidty (ADCC) through CD16. The <x-flTCR  + 
LGL  show  similar cytotoxic activity against NK-sensitive 
YAC-1  cells.  Furthermore,  cytotoxic  activity  is  induced 
through both CD16  and the TCK  (26).  Since 3,-STCR + 
LGL  cells  are  phenotypically  similar  to  both  NK  and 
o~-flTCR + LGL cells, we next examined the cytotoxic ac- 
tivity of these cells. As shown in Fig. 6,  splenic ~/-/~TCK + 
LGL cells show strong cytotoxic activity against YAC-1 cells. 
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Figure  5.  Phenotypes of ILL cells obtained 
from purified DNot-flTCR + , DN3,-STCR § 
and DN-TCR-  splenocytes. DNsIg- spleno- 
cytes were purified by magnetic separation and 
further  stained with  FrrC-conjugated H57 
(anti-Cfl) and biotinyh~ 3A10 (anti-~) fol- 
lowed  by RED670-conjugated streptavidin as 
shown  in  Hg.  3  A.  DNa-/~rCR §  (A), 
DN3,-~TCR + (B), and DN-TCR-  (C) cells 
were then sorted by a FACS~/antage and 5  x 
10  s cells with a purity of >85% were obtained 
for each population. Purified cells were then 
cultured in the presence of IL2. On day 12, 
cells were stained with various biotinylated  an- 
tibodies as indicated foUowed by RED670- 
streptavidin as described in Fig. 2.  (a) 2.4G2 
(anti-v~pdI/m), (~) TM~-I (anti-n.2g/~),  (c) 
PC61 (anti-IL2Rcx),  (d) PK136 (anti-NKl.1), 
(e) 500A2  (anti-CD3r  (D RA3-6B2 (anti- 
B220), and (g) CG16 (anti-CDS), 3A10 (anti- 
CaS; negative control for the ot-/~'CR + ILL 
and  TCR-  ILL),  H57  (anti-Cfl;  negative 
control for the 3-8TCR + ILL). TCR- ILL 
cells were also stained with FITC-conjugated 
2Cll to exclude a fraction (•10%)  of cells ex- 
pressing CD3/TCR. _~80 
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Figure  6.  Cytotoxic activity  of 3"-STCR + LGL. Splenic  "y-/~TCR  + 
LGL (.4) and thymic 3'-/~TCR + LGL (B) were obtained  from purified 
DNT-~TCR + splenocytes and thymocytes by cultivation  with I1.2 for 
2 and 3 wk, respectively. Cytotoxic activities against YAC-1 (O), 2.4(32 
hybridoma (O), 3A10 hybridoma (A), autologous (C57BL/6) Con A blasts 
(A, A), or H57 hybridoma (I,  B) were examined by a standard stCr- 
release assay with the indicated director/target  ratios. 
Cytotoxic activities wex'e also induced through Fc~R and TCR 
molecules examined by redirected cytolysis against B cell hy- 
bridomas producing mAbs 2.4G2 (anti-FeyRII/III) and 3A10 
(anti-C~),  respectively.  Thymic y-#TCR + LGL  cells also 
showed cytotoxic activities, although the activities were weaker 
than those of splenic LGL cells. These results  indicate that 
the ~,-/~TCR + LGL cells, like ot-3TCR + LGL cells, have 
cytotoxic activity similar to that of NK cells. 
PCR Analysis of  Fc~R Isotype  and Expression of  FceRI~,  and 
CD3~.  The mAb 2.4G2 is known to recognize three dis- 
tinct FeyR isotypes, FcTRIIbl (lymphocyte  form), FeyRIIb2 
(monocyte form), and Fc3,RIII (CD16)  (64,  67,  68).  We 
thus examined the expression of these molecules in DN thymo- 
cytes and LGL cells by reverse PCR analysis as described 
previously (26). To this end, cDNAs were synthesized from 
total RNA prepared from 0.5-1  x  106 cells and PCR was 
performed with amplimers specific for each  molecule. As 
shown  in  Fig.  7,  Fc3,R  on  DNot-BTCR +  thymocytes, 
oe-BTCR + LGL,  and 3'-/~TCR + LGL is exclusively of the 
CD16 form whereas unfractionated DN thymocytes express 
all three FcTR isotypes (Fig. 7, panels d and e). In contrast 
to DNoe-BTCR + thymocytes or LGLS, DNy-/~TCR + thy- 
mocytes do not express any FeyR isotypes as expected from 
the flow cytometric analysis  (Fig. 1 C). PCR amplimers specific 
for FceRI3,  detected the expression  of FceRI~ mRNA in 
unfractionated DN thymocytes, DNcc-BTCR + thymocytes, 
c~-BICR + LGL and 3,-/JTCR + LGL (Fig. 7 c). The amount 
of FceRI3, mRNA is, however, much higher (>20-fold) in 
Figure  7.  PCR analysis ofFc~,R isotype and expression of FceRI3, and 
CD3~'. Total cellular RNA was prepared from 0.4-1  x  106 CD4 + SP 
thymocytes, unfractionated DN thymocytes, DNot-~ffrCR + thymocytes, 
DNT-6TCR + thymocytes, ot-~lCR+  LGL, and 3"-/~TCR  + LGL cells. 
cDNA copies were produced from total cellular RNA using an oligo dT 
primer and AMV reverse transcriptase and used as a temphte for PCR 
with primers for CD3/~ (a), CD3~"  (b), FceRI3" (c), CD16/FeyRIII (d), 
or Fc3`RII (e) as described in Materials and Methods. PCR products from 
10  4 cells were resolved on a 1.5% agarose gels and visualized by ethidium 
bromide staining  (a) or Southern  blotting followed by hybridization  to 
internal oligonudeotides (b-e) as descnq~ed  in Materials and Methods. Films 
were exposed for 2 h except that those for (e) and ~-/~'CR + LGL (b) 
were e~posed for 12 h. (bl and b2, e) Migration positions for PCR prod- 
ucts from FeyRIIbl (lymphocyte form) and FeyRIIbz (monocyte form), 
respectively. 
LGLs than in DNol-BTCR § thymocytes. A longer exposure 
of the film showed a small amount of FceRI3, mRNA ex- 
pression  in  DN3,-STCR +  thymocytes but  no  detectable 
band  was  obtained from  CD4+SP  thymocytes (data  not 
shown). Finally, CD3~" and CD36 mRNAs were observed 
in all cells tested including CD4 + SP thymocytes (Fig.  7, 
a and b). These results indicate that both CD16 and FceRI3, 
molecules are expressed in DNc~-flTCR + thymocytes and 
their  expression  is  induced in  DN3,-/~TCR +  thymocytes 
upon IL2 stimulation. 
Association of FceRI~, with TCR and CD16 Molecules on 
LGL.  Since CD3~'and FceRI  3, are important in the surface 
expression of both TCR and CD16, we next examined the 
Figure  8.  Association of FceRI~/with TCR and CD16 molecules on LGL. Thymus-derived  c~-31"CR  + LGL (.4., panels a-c) and 3,-6TCR § LGL 
cells (B) and lypmh node--derived Con A blast cells (,4, panel d) were lysed in 1% digitonin lysis buffer solution. Postnuclear supernatants were immuno- 
precipitated  by CNBr-activated  Sepharose CL4B beads conjugated  with (a) 3A10 (anti-C~),  (b) H57 (anti-CB),  (c) 2.4G2  (anti-Fc3`RII/III),  or (d) 
1~A1 (anti-CD3~. Immunoprecipitates  were resolved by two-dimensional  norrreducing/reducing  diagonal gels and Western blotted with rabbit an- 
tisera #387 (anti-CD3~ or 3"666 (anti-FceRIT).  Proteins were visualized by the enhanced chemiluminescence detection  method (Amersham Interna- 
tional).  Numbers on the left side indicate the migration positions of prestained molecular weight markers (Bethesda Research Laboratories). 44 kD, 
OVA; 29kD, carbonic anhydrase; and 13 kD lysozyme. (Open and closed triangles) CD3~'in CD3~'-FceRI3, heterodimers, and CD3~"  homodimers,  respec- 
tively. (Open and closed arrows) FceRI'y in CD3~'-FceRI3, heterodimers  and FceRI  3, homodimers,  respectively. 
1964  FceRI  T containing  TCR on CD3+CD16+NKl.l+B220 + LGL 1965  Koyasu association of these molecules with TCK and CD16 mole- 
cules on c~-3TCR + LGL and 3/-$TCK + LGL. As shown in 
Fig. 8, CD3~'-FceRI3/heterodimers  and FceRI3/homodimers 
were readily detected in association  with TCRs on both 
ot-3TCR + LGL (Fig.  8 A,  panel b) and 3/-/STCR + LGL 
(Fig. 8, panel a), whereas only FceRI3/homodimers are ob- 
served in the CD16 immunoprecipitates (Fig. 8 A, panel c 
and Fig. 8 B, panel c). Anti-CD3~'mAb immunopredpitates 
both CD3~" homodimers and CD3~'-FceRI3/heterodimers 
(Fig. 8 B, panel d) but little CD3~" homodimers are detected 
in association with the TCR or CD16 complexes (Fig. 8 A, 
panels b and c and Fig.  8 B panels a and c). In contrast to 
LGL, CD3~" homodimers but not FceRI3/were detected in 
Con A blasts derived from lymph node cells; these cells do 
not express FeyR or NKI.1 (Fig. 8 A, panel d and data not 
shown). 
Discussion 
We have previously reported that long-term LGL cultures 
obtained from splenocytes incubated with IL2 show an un- 
usual surface phenotype coexpressing CD3/ot-3TCR and 
CD16 in the absence of CD4 and CD8 (26).  CD16 is ex- 
pressed on NK cells but not on "conventional" T lympho- 
cytes in adult animals with rare exceptions such as the T cells 
found in LGL lymphocytosis patients (69, 70). In addition, 
these cells express NKI.1 and exhibit strong cytotoxic ac- 
tivity against NK-sensitive YAC-1 cells. Cytotoxic activities 
can be induced through both TCK and CD16 structures. Thus, 
these LGL cells have characteristics of both T and NK cells. 
In fetal thymic development, TCR-  fetal thymocytes are 
nearly  100%  CD16 +  and differentiate to T  lymphocytes 
within the thymus but differentiate  to NK cells when cul- 
tured with IL2 in vitro, indicating that CD16 + fetal thymo- 
cytes contain precursors  of both T  cells and NK cells (71). 
We herein demonstrate that both thymic and splenic DN 
cells in adult animals contain a population coexpressing ot- 
3FCR, CD16, and NKI.1. These cells become LGL upon 
IL2 cultivation and exhibit surface phenotypes identical to 
those of LGL reported previously (26). It is therefore likely 
that these DNot-3TCR + cells are the precursors  of IL2- 
induced LGL. In contrast to conventional SP thymocytes or 
mature T  lymphocytes, DNot-BTCR + cells constitutively 
express the 3  subunit of IL2K without expressing the ol 
subunit (Figs. 1 and 2; 72). Since the/3 subunit of IL2R in 
combination with the 3/subunit is responsible for transmit- 
ting signals (73), these cells likely express the 3, subunit of 
IL2R and can respond to IL2 without antigenic stimulation. 
To our surprise,  IL2 stimulation of purified DN3/-/STCR + 
cells also generated cells morphologically, phenotypically, and 
functionally identical to LGL. The purified DN3/-6TCR + 
cells do not express CD16 or NKI.1 but acquire expression 
of these molecules after cultivation with IL2. In contrast to 
the human 3/-6TCK + cells (74) or DN3/-/STCR + spleno- 
cytes, mouse DN3/-/STCR + thymocytes express little IL2R3 
as examined by flow cytometry (Fig. 1 C) and yet this popu- 
lation respond to IL2 without stimulation through the TCR. 
It is possible that binding of mAb to the 3/-$TCR during 
cell sorting activates the DN3/-6TCR + cells and induces the 
IL2R. This possibility is, however, unlikely because expan- 
sion of DN3/-/STCK + LGL was also observed from unfrac- 
tionated DN thymocytes (data not shown). It is unknown 
whether these cells express the IL2Pd3/3/complex at a low 
level or express a distinct type of IL2R. Although the majority 
of the purified DN3/-/STCR + thymocytes survive during II,2 
cultivation, we cannot formally rule out the possibility that 
a small portion of the DN3/45TCR + population expressing 
IL2R3 respond to IL2, thus producing the DN3/-gTCR + 
LGL. 
DNc~-3TCR +  thymocytes  express  CD16  mKNA  as 
shown by PCR analysis (Fig. 7). The level of CD16 mRNA 
expression  seems unchanged but the surface expression  of 
CD16 detected by the 2.4G2 mAb is greatly enhanced after 
IL2 cultivation. CD16 requires FceRI3/or CD3~"  for its trans- 
portation to the cell surface. In the human, the CD16 mole- 
cule can  associate  with  homo- or  heterodimers between 
FceKI3/and CD3~" (22, 23). In contrast, mouse CD16 is un- 
able to associate with CD3~" either as a homo- or a hetero- 
dimer with Fc~RI3/(Fig. 8). This result confirms the previous 
report that mouse CD3~'cannot associate with CD16 in trans- 
fection experiments (20).  The DNc~-BTCR + thymocytes 
express FceRI3/mRNA at a low level whereas CD3~"  mKNA 
is expressed at a level similar to that of CD4 + SP thymo- 
cytes (Fig.  7). The level of the FceRI3/mRNA expression 
is, however, dramatically increased upon IL2 cultivation. It 
is therefore likely that the IgG binding subunit (CD16) is 
expressed at the mRNA level but that the level of FceRI3/ 
subunit limits CD16 surface expression in this population. 
In contrast to the DNoe-3TCR + thymocytes, DN3/-6TCR + 
thymocytes do not  express  any  detectable  level of CD16 
mRNA. However, this population is induced to express both 
CD16 and FceRI3/mRNAs after cultivation with IL2 and 
acquires the surface expression of CD16. It has been reported 
that CD16 surface expression is induced on V3/3 + skin in- 
traepithelial lymphocytes (slEL) after stimulation with Con 
A and IL2 (75).  It is possible from our results that IL2 is 
the major inducer of CD16 on slEL. 
FceRI3/plays an important role in the expression of CD16 
as well as FceRI and as shown herein, this molecule is also 
a subunit of TCRs in LGL. The TCKs on LGL cells are as- 
sociated with CD3~'-FceRI3/heterodimers as well as FceRI3/ 
homodimers (Fig. 8). We have previously reported that the 
TCR on long-term IL2-&iven LGL cells is associated with 
FceKI3/homodimers without CD3~'/7/(26). The latter LGL 
cells were cultured for a longer time in vitro with IL2 than 
those reported here and it is possible  that they lost CD3~" 
protein expression after long in vitro cultivation. In fact, the 
level of FceKI3/mKNA is increased dramatically after IL2 
cultivation whereas that of CD3~" is decreased (Fig.  7 and 
data not shown). At the protein level, LGLs derived from 
DNot-/$~CR + and DN3/-~TCR + thymocytes gradually lost 
the expression of CD3~'and the amount of the TCR-associated 
FceRI3/homodimer  increased (data not shown). It seems there- 
fore likely that the FceKI3/homodimer becomes the major 
component of the TCR after prolonged cultivation of these 
1966  FceRI3~  containing  TCR on CD3+CD16+NKl.1+B220  + LGL cells in 11.2. Similar changes in subunit composition have been 
reported in tumor-bearing mice. Mizoguchi et al. (27) ob- 
served that most T cells express TCILs associated  with FceRI3, 
homodimers in mice after growth of implanted tumors. It 
is unknown, however, whether these two cases are related. 
Although not associated  with the TC1L CD3~'homodimers 
are also present in the cell as shown by biochemical analysis 
(Fig. 8). Orloff et al. (25) have reported that the CTLL cell 
line expresses CD3~', CD3~/, and FcelLI3,, but the major com- 
ponent of the TCR is the CD3~'-FceRI  3, heterodimer. It seems 
likely from these results that the CD3~'-EceRI3, beterodimer 
has a higher affinity for the TCR than the other dimers. In 
contrast to the TCR, only FceRIqr homodimers are capable 
of association with CD16 in the same cell (Fig. 8). We were 
unable to perform biochemical analysis of the TCR compo- 
nent  in  freshly  isolated  DNoe-/YICR +  or DN3,-/~TCR + 
thymocytes because of insufficient cell numbers.  However, 
since the DNoL-~'CR + thymocytes express both FceRI3, 
and CD3~', it is likely that the TCR on this population con- 
tains both FceRI3'  and CD3~'. 
Using a mAb against FceRI3,, Vivier et al. (28) reported 
that this subunit is expressed in human thymocytes and pe- 
ripheral T cells in both CD4 and CD8 subsets and is associated 
with the TCR. In contrast to the human, as shown here in 
mouse, mRNA for FceRI3, was not detected in CD4 + SP 
cells (Fig. 7) or DP cells (data not shown) by PCR. Malissen 
et al. (76) and Liu et al. (77) have recently demonstrated that 
intestinal  intraepithelial  lymphocytes (ilEL) express TCRs 
containing  FceRIqr by  employing  CD3~'-CD3~/-  mice 
which lack most T  lymphocytes due to the deficiency in 
CD3~'hl expression. These ilEL cells are known to develop 
extrathymically and have a distinct  selection pathway from 
that of conventional T lymphocytes (78-80).  These results 
together with our results indicate that the FceRI'y subunit 
is expressed in distinct  subsets of T  cells. 
It has been suggested that T and NK cells are of the same 
developmental origin.  Fetal thymocytes can differentiate in 
vivo to T lymphocytes  when transferred into the thymus but 
differentiate to NK cells when cultured with IL2 in vitro, 
indicating that fetal thymocytes contain precursors of both 
T  and NK cells (71). It has also been shown that CD16 + 
NKI.I+TCR-NK  cells are  induced  by  cultivation  of 
CD16-NKI.1- fetal  liver cells with IL2 (81), indicating that 
both CD16 and NKI.1 can be induced by IL2. Our results 
that IL2 cultivation of DNo~-BTCR + or DNq,-gTCR + cells 
from both thymus and spleen results in the generation of 
LGL that are characteristic of NK cells support the hypoth- 
esis that T and NK cells are of same developmental origin. 
Nearly 100%  of day 14.5 fetal thymocytes express CD16 
without the CD3/TCR complex but los CD16 expression 
and acquire CD3/TCR expression upon further development 
(71). FceRI'y is associated with CD16 in such early thymo- 
cytes but its expression is downregulated during the induc- 
tion of TCR expression in association with CD3~'. It is pos- 
sible that a small population of thymocytes continues to express 
both CD16 and the FceRI3, subunit and that such a popula- 
tion  is  the  precursor  of the  DNol-~TCR +  thymocytes 
(Fig. 9). 
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DNol-/3TCR + cells have been observed in both humans 
and mice. In mice, these cells are not detectably observed 
during fetal development but appear in the thymus after birth, 
implying a distinct developmental program for this popula- 
tion (1). DNoe-~K  + cells have also been observed in var- 
ious other organs such as spleen, lymph node, bone marrow, 
peripheral blood, liver, and intestine (29-42).  It is unclear, 
however, whether these cells are of the same origin or are 
derived from separate developmental pathways in different 
organs. Thymic dependence is also controversial. For example, 
DNot-ffrCK + cells are found in the spleen of athymic nude 
mice but not in bone marrow (35, 38),  suggesting that a 
portion of DNc~-~TCR + cells develop extrathymically but 
that those in bone marrow require thymus for their develop- 
ment.  DNc~-~TCR +  cells were  observed  in  the  lymph 
nodes after intrathymic cell transfer of CD3- CD4-CDS- 
thymocytes,  indicating that  at  least  a  portion  of DNol- 
~/TCR + cells are of thymic origin (32). Levitsky et al. (36) 
showed that thymus engraftment into atbymic mice resulted 
in the development  of donor type DNot-~TCR+NKI.1 + 
cells in periphery and that the DNol-~TCR+NKI.1 + cells 
preferentially localize to bone marrow. As shown in Fig. 1, 
only 60-70% of DNo~-~TCK + splenocytes express NKI.1 
whereas nearly 100% of DNc~-~TCR + thymocytes express 
NKI.1, thereby revealing  at least two distinct subsets of  DNo~- 
BTCR + cells in spleen. It is therefore possible that there are 
several different subsets of DNc~-~TCR + cells whose devel- 
opment is either dependent or independent of thymus (Fig. 
9). Likewise, both thymic-dependent and -independent de- 
velopment are known for the 3,-3TCR+cells (Fig. 9;  1, 9, 
78-80, 82). Although our results strongly indicate that DNo~- 
~TCR + cells expressing NKI.1 are the precursors of IL2- 
induced LGL or LAK cells, it is not clear whether other DNol- 
~TCR + cells are also able to differentiate to LGL upon cul- 
tivation  in the presence of IL2. 
IL2-induced LGL cells also are characterized by the expres- 
sion of the B220 epitope of the CD45 molecule defined by 
mAb RA3-6B2.  Freshly isolated DNo~-BTCR + and DN3'- 
6TCR + cells do not express B220. It is interesting to note 
that in both cell types, cultivation with IL2 downregulates 
CD5 but induces the B220 epitope. Although the B220 epi- 
tope was originally considered to be a B cell-specific marker 
(83), evidence has accumulated that this epitope can be ex- 
pressed not only on B cells but also on T lineage cells upon 
activation in both c~-~I"CR  + and "y-STCR  + cells (30, 84). 
The CD45 molecule expressing the B220 epitope on such 
T cells has a different molecular weight from that on B cells 
(85). DNot-~'CR+B220 + cells are well known to be ex- 
panded in autoimmune MLR/Ipr  mice (29, 43,  44).  The 
DNc~-/~TCR+B220 + population expanded in Ipr/Ipr mice, 
however,  seems  to  be  a  different  cell  type from  DNoL- 
BTCR+NKI.1 + cells. The DNc~-BTCR+B220 + cells ex- 
panded in llyr/Ipr  mice lack IL2RB and NKI.1 expression (86, 
87). Takeda and Dennert (87) reported an inverse correlation 
between the level of DNc~-BTCR+NKI.1 + cells and the ap- 
pearance of DNot-flTCK +  B220 +  NKI.1 - cells, which indi- 
cates the onset of autoimmunity in Ipr/Ipr mice. It was also 
shown that the injection of mAb against NKI.1 enhances DN  "~-~[iiii  Stem  Cell Pool I 
DN  ~.":[".'!'[)'.'.['~  [.[.[[:[.:'..;'.~:-.':j-.:~?[:~[-:.~  CD18  + DN  '~[.[[-'.'.'.[[-:.:~:..':::;"[[~;'-i'-.[?.':':}';"[~-.'~.')-i-:':[-i] ~'::":.",i-'[."[[".'.~ 
a - !3  TC R ~~."'[~  TCR-  l~~:i:[l  DN 
CDt6-DP  t  ,....:v-u  , 
~'~C~' +"  ~d:~::l  CD16-SP  Y:.':!  .....  + 
.+  [:!:1 
#  ￿9 
IL2s"  ~?.'.I~.',I~-C  ..., , ,..:~',.","ii'i;  ￿9149 
##  ￿9 
ct_~TCR +  Conventional 
T  ~,-STCR § 
kLyrnphocytesj  ,  NKI.1-  ,  /E  I~ 
c~-6TCR + 
NK1.1 - 
Fipre 9.  Mndd  for the de~op- 
rnent OfDN I.GL cells  in adult 
CD16+DN-TCR-NK1.1 -  intra- 
thymic precursor ceils derived from 
hematopoietic  stem  cells differen- 
tiate to DP cells ~l~'essing  a low 
level  of  TCR/CD3  (TCR -/l~ 
and further differentiate to CD4 + 
CD8- or CD4-CD8 + SP cells L~- 
pressing  a  high  level  of  surface 
a-/TrCR/CD3  complex  (1,  71). 
These con~mtional SP cells emigrate 
into peripheral lymphoid organ. In 
addition to these conventional SP T 
lymphocytes,  DN  cells  expressing 
TCR are present in carious organs. 
In thymus, a fraction of thymocytes 
continues to express both CD16 and 
the FceRI3' subnnit  and  differen- 
tiate  to the DNot-AffrcR  +  CD16  + 
NKI.1 +  thymocytes.  These  cells 
emigrate to spleen, lymph node, and 
bone marrow. In contrast to DNa- 
AffrCR  + cells,  DNT-~TCR  + cells 
do  not express  CD16  or NKI.1. 
Both DN~tffI'CR+CD16*NK1.1* 
and DN3'-/}TCR  +  CD16 - NKI.1 - 
cells in thymus and spleen further 
differentiate by IL2 stimulation  to 
DN ot-B TCK + CD16 + NKI.1 + 
B220 § and DN~,-STCR+CD16 + 
NKl.1+B220 + LGL, respectively. 
At least a fraction of DNoe0TCR  + 
cells in bone marrow and liver de- 
velop extrathymicelly  (40, 41). We 
CannOt rule out the possibility that 
cells which dg~lop extrathymicelly 
immigrate to the thymus.  DN')'- 
8TCR +  cells  found  in  the  skin 
(slEL  ) are derived from thymus and 
are induced  to express CD16 and 
B220 upon activation (74, 82, 84). 
"),-STCR + cells found in intestine 
(gEL)  develop  extrathymically 
(78-80).  It is not known whether 
all DN-TCR + cells respond to IL2 
and  differentiate  to LGL. Among 
the populations  shown, DNa-3TCR+CD16+NK1.1 + cells, DNo~-~TCR+CD16+NK1.1+B220 + LGL, DN3,-~TCR+CD16+NK1.1+B220 + LGL, 
and ilEL have been  shown to express FceRI  7  as a component of the TCR (this article,  and 76,  77). 
the appearance of DNcc-/3TCR+B220 + cells and autoimmu- 
nity, whereas  adoptive  transfer  of DNot-/~TCR+NKI.1 + 
cells of normal mice suppressed these symptoms.  It is thus 
likely that  DNc~-/~TCR+B220 + cells expanded  in Ipr/Ipr 
mice are  of a  distinct  origin  as  compared with  DNc~- 
/3TCR +  NKI.1 + cells and that DNol-3TCR +  NKI.1 + cells 
have an immunosuppressive ability. It is of interest, from this 
point  of view,  that  DNo~-~TCR+NKI.1 +  cells in  bone 
marrow also exhibit immunosuppressive activity and seem 
to function in acute bone marrow graft rejection (38, 39). 
DNol-/3TCR + thymocytes lack CD4  and CDS,  which 
are important in thymic selection. Indeed, the V gene reper- 
toire of DNol-~TCR + thymocytes suggests that this popu- 
lation does not undergo normal thymic selection pathways 
and contains autoreactive cells (88, 89). This is possibly be- 
cause of the lack of CD4/CD8 expression. Alternatively, it 
is possible that the TCRs containing FceRI3, subunits transmit 
distinct  signals when interacting with thymic MHC mole- 
cules resulting in different sdection mechanisms. From this 
point of view, it is of interest  that CD3~'/~/, FcdLI'),, and 
other CD3 subunits contain an amino acid sequence motif 
originally pointed out by Reth (YxxLxxxxxxxYxxL) (90). 
Whereas this motif  is repeated three times in CD3~"  and twice 
in CD3~/, FceRI3, has only one motif with different sur- 
rounding sequences. Studies with chimeric molecules con- 
sisting of the intraceUnlar portion of proteins containing this 
1968  FceRb/containing TCR on CD3+CD16+NK1.1+B220 + LGL motif  connected with an extraceilular domain of an unrehted 
receptor molecule show the importance of this motif and 
qualitative differences in signal transduction between motifs 
derived from distinct molecules (91-97).  Key signal trans- 
duction molecules  such  as  p56~  and/or ZAP70  may be 
differentially associated  with  distinct TCK  isoforms and 
transmit different signals.  In this context, it is of note that 
in LGL, an devation of the intracellular cAMP level, but not 
a combination of Ca  z+ mobilization and activation of pro- 
tein kinase C, induces expression of the IL2Rc~ subunit (46) 
in contrast to the findings in conventional T lymphocytes  (98). 
In  summary,  we  have  demonstrated  that  DN-TCR + 
CD16+NK1.l+B220+CD5 -  LGL cells are induced by IL2 
from both DNo~-~TCR+CD16+NKl.l+B220-CD5 + and 
DN3~-~TCR +  CD16 - NKI.1 - B220- CD5 + cells present in 
thymus and spleen.  FcdLI3~ is  expressed  in freshly isola- 
ted DNc~-~TCR+CD16+NKl.l+B220-CD5 + but not in 
DN3~4~TCR +  CD16- NKI.1- B220- CD5 + thymocytes. In- 
cubation of these cells with IL2 greatly induces the expres- 
sion of FceRI  3, and the TCR contains FceRI'y as a subunit 
in the resulting LGL. It is now critical to ascertain the func- 
tion of distinct CD3~'h/-FceKb/dimers in signal transduc- 
tion and in the development of the DNot-BTCR + popu- 
lation. 
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